# Bittium Biosignals extends supply agreement with Preventice Solutions for ECG monitoring devices

Bittium Biosignals, a subsidiary of Bittium Corporation, signed an extension agreement with Preventice Solutions (a Boston Scientific subsidiary) to supply BodyGuardian MINI ECG monitoring devices. The agreement is valued at approximately USD 40-45 million, with revenues accruing from 2022 to 2025.

- Type: Contract
- Announced: 2022-02-02
- Value: $45.0M
- Status: announced
- Products: BodyGuardian MINI ECG monitoring devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Bittium](https://endata.com/companies/31429.md)
- [Bittium Biosignals Ltd](https://endata.com/companies/49832.md)
- [Boston Scientific](https://endata.com/companies/15966.md) (partner)
- [Preventice Solutions, Inc.](https://endata.com/companies/52693.md) (customer)

## Sources

- [news.cision.com](https://news.cision.com/bittium-oyj/r/bittium-corporation-s-subsidiary-bittium-biosignals-ltd-and-preventice-solutions-have-signed-an-exte,c3496997), 2022-02-02: "We are happy to strengthen this strategic relationship with this agreement."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.